Related Experiment Videos
Unilateral methotrexate-induced pneumonitis
Journal of the National Medical Association
|September 1, 1980
Summary
Unilateral methotrexate-induced pneumonitis is a rare condition. This case study explores its development and likely cause in a patient with tonsil cancer and lung metastasis causing unilateral pulmonary artery obstruction.
Area of Science:
- Oncology
- Pulmonology
- Pathology
Background:
- Methotrexate is a common chemotherapy agent.
- Methotrexate-induced pneumonitis typically presents with bilateral lung involvement.
- The pathogenesis of unilateral methotrexate-induced pneumonitis remains poorly understood.
Observation:
- A patient with tonsil carcinoma metastatic to the lung developed unilateral pneumonitis.
- The patient had unilateral pulmonary artery obstruction due to metastasis.
- This presentation is atypical for methotrexate-induced pneumonitis.
Findings:
- This case presents the first reported instance of unilateral methotrexate-induced pneumonitis.
- The unilateral presentation is likely linked to the unilateral pulmonary artery obstruction.
- The probable pathogenesis involves localized drug toxicity exacerbated by impaired pulmonary circulation.
Implications:
- This finding expands the spectrum of methotrexate-induced pneumonitis.
- It highlights the importance of considering localized vascular obstruction in atypical drug-induced lung injuries.
- Further research is needed to elucidate the precise mechanisms and clinical management of unilateral methotrexate pneumonitis.